FN2 Earnings Intelligence
Amgen Inc. financials
Amgen Inc. (AMGN) financial statements and key operating metrics from FN2 Research.
Key Stats
USD in millions, except per-share values and percentages.
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2024 | 12/31/2025 | 12/31/2026 est. | 12/31/2027 est. |
|---|---|---|---|---|---|---|---|
| Market Cap | - | - | - | - | - | - | - |
| - Cash | $7,989 | $7,629 | $10,944 | $11,973 | $9,129 | - | - |
| + Debt | - | - | - | - | - | - | - |
| Enterprise Value | - | - | - | - | - | - | - |
| Revenue | $25,979 | $26,323 | $28,190 | $33,424 | $36,751 | $38,956.6 | $40,334.1 |
| % Growth | 2.2% | 1.3% | 7.1% | 18.6% | 10.0% | 6.0% | 3.5% |
| Gross Profit | $19,525 | $19,917 | $19,739 | $20,566 | $24,714 | - | - |
| % Margin | 75.2% | 75.7% | 70.0% | 61.5% | 67.2% | - | - |
| EBITDA | $11,037 | $12,983 | $11,968 | $12,850 | $14,247 | - | - |
| % Margin | 42.5% | 49.3% | 42.5% | 38.4% | 38.8% | - | - |
| Net Income | $5,893 | $6,552 | $6,717 | $4,090 | $7,711 | - | - |
| % Margin | 22.7% | 24.9% | 23.8% | 12.2% | 21.0% | - | - |
| Diluted EPS | $10.28 | $12.11 | $12.49 | $7.56 | $14.23 | $23.08 | $24.42 |
| % Growth | -16.5% | 17.8% | 3.1% | -39.5% | 88.2% | 62.2% | 5.8% |
| Operating Cash Flow | $9,261 | $9,721 | $8,471 | $11,490 | $9,958 | - | - |
| CapEx | $880 | $936 | $1,112 | $1,096 | $1,858 | - | - |
| Free Cash Flow | $8,381 | $8,785 | $7,359 | $10,394 | $8,100 | - | - |
Historical market capitalization is not persisted, so Market Cap and Enterprise Value remain unavailable rather than mixing today's market value into prior periods.
Income Statement
USD in millions, except per-share values and percentages.
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2024 | 12/31/2025 | 12/31/2026 est. | 12/31/2027 est. |
|---|---|---|---|---|---|---|---|
| Revenue | $25,979 | $26,323 | $28,190 | $33,424 | $36,751 | $38,956.6 | $40,334.1 |
| Gross Profit | $19,525 | $19,917 | $19,739 | $20,566 | $24,714 | - | - |
| EBITDA | $11,037 | $12,983 | $11,968 | $12,850 | $14,247 | - | - |
| Net Income | $5,893 | $6,552 | $6,717 | $4,090 | $7,711 | - | - |
| Diluted EPS | $10.28 | $12.11 | $12.49 | $7.56 | $14.23 | $23.08 | $24.42 |
Balance Sheet
USD in millions, except per-share values and percentages.
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2024 | 12/31/2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | $7,989 | $7,629 | $10,944 | $11,973 | $9,129 |
| Short-term Debt | - | - | - | - | - |
| Long-term Debt | $33,222 | $37,354 | $63,170 | $56,549 | $50,005 |
| Total Debt | - | - | - | - | - |
Cash Flow
USD in millions, except per-share values and percentages.
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2024 | 12/31/2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | $9,261 | $9,721 | $8,471 | $11,490 | $9,958 |
| Capital Expenditure | $880 | $936 | $1,112 | $1,096 | $1,858 |
| Free Cash Flow | $8,381 | $8,785 | $7,359 | $10,394 | $8,100 |
Ratios
USD in millions, except per-share values and percentages.
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2024 | 12/31/2025 |
|---|---|---|---|---|---|
| Revenue Growth | 2.2% | 1.3% | 7.1% | 18.6% | 10.0% |
| Gross Margin | 75.2% | 75.7% | 70.0% | 61.5% | 67.2% |
| EBITDA Margin | 42.5% | 49.3% | 42.5% | 38.4% | 38.8% |
| Net Margin | 22.7% | 24.9% | 23.8% | 12.2% | 21.0% |
| FCF Margin | 32.3% | 33.4% | 26.1% | 31.1% | 22.0% |
| Diluted EPS Growth | -16.5% | 17.8% | 3.1% | -39.5% | 88.2% |